GlassScriptPhysician profile
Snehal Ishwar Patel
NPI 1396903837
$2,613.76
in general payments reported to CMS, 2019-2025
10 companies · $676 in 2025
The $676 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.72 · 2021: $42.28 · 2022: $552 · 2023: $504 · 2024: $821 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,002.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,149.04 | 2021-2025 | Corevalve Evolut R |
| Inari Medical, INC. | $922.55 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cvrx, INC. | $151.57 | 2025 | Barostim Neo System |
| Cardiva Medical, INC. | $147.60 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $100.20 | 2022 | |
| Philips North America LLC | $51.30 | 2024-2025 | (Ck7) Extended Holter, Extended Holter |
| Teleflex LLC | $33.97 | 2023-2025 | Manta, Supercross |
| Angiodynamics, INC. | $28.92 | 2025 | Alphavac |
| Biocompatibles, INC. | $16.72 | 2019 | |
| Chiesi USA, INC. | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Snehal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.